The multisubunit IkappaB kinase complex shows random sequential kinetics and is activated by the C-terminal domain of

J R Burke1, K R Miller, M K Wood

  • 1The Department of Drug Discovery Research, Bristol-Myers Squibb Pharmaceutical Research Institute, Buffalo, New York 14213 USA.

Insights

The IkappaB kinase (IKK) enzyme uses a sequential binding mechanism for its substrates, IkappaB alpha and ATP. Unexpectedly, the C-terminal peptide of IkappaB alpha acts as an allosteric activator, enhancing N-terminal peptide phosphorylation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • The IkappaB kinase (IKK) complex is crucial for activating the transcription factor NF-kappaB.
  • IKK catalyzes the phosphorylation of IkappaB alpha, a key regulatory step preceding NF-kappaB release.
  • Understanding IKK substrate binding and regulation is vital for controlling inflammatory and immune responses.

Purpose of the Study:

  • To elucidate the kinetic mechanism of IKK-catalyzed IkappaB alpha phosphorylation.
  • To investigate the role of different IkappaB alpha regions in enzyme interaction and regulation.
  • To identify potential allosteric regulation of IKK activity.

Main Methods:

  • Enzyme kinetics using 33P incorporation to measure IKK activity.
  • Characterization of substrate binding constants (dissociation constants) for GST-IkappaB alpha and ATP.
  • Inhibition studies using N-terminal and C-terminal IkappaB alpha peptides to probe active site and allosteric interactions.

Main Results:

  • IKK follows a random sequential binding mechanism with GST-IkappaB alpha and ATP.
  • Both N-terminal and C-terminal IkappaB alpha peptides are substrates for IKK.
  • The C-terminal peptide acts as an allosteric activator, significantly increasing the phosphorylation rate of the N-terminal peptide.

Conclusions:

  • IKK possesses an allosteric site that recognizes the C-terminus of IkappaB alpha, enhancing its catalytic activity.
  • This allosteric interaction represents a novel regulatory mechanism for IKK substrate recognition and phosphorylation.
  • Findings provide new insights into NF-kappaB pathway regulation and potential therapeutic targets.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...